Workflow
Pet Health Services
icon
Search documents
Chewy vs. Walmart: Which Is the Better Way to Invest in Pet Spending?​
The Motley Fool· 2026-02-02 06:00
Core Insights - Chewy is a niche player in the pet industry, while Walmart offers a broader range of retail products, including pet supplies [1][2] - The pet care market is projected to grow at a 5.1% CAGR until 2030, but Chewy's reliance on the low-margin pet industry raises concerns about its growth potential compared to Walmart [2][3] Company Performance - Chewy has low net profit margins, typically in the low single digits, while Walmart's margins range from 3% to 4% [3][11] - Chewy is diversifying into pet health, which has a higher average net profit margin of 20%, and currently operates over 20 veterinary practice locations [4] - Chewy's stock has decreased by nearly 70% over the past five years, reflecting challenges in maintaining growth post-pandemic [10] Financial Metrics - Chewy's current market cap is $12 billion, with a P/E ratio of 67, while Walmart's market cap is $950 billion with a P/E ratio of 42 [5][9][10] - Walmart's revenue growth was 5.8% year-over-year in Q3 FY26, compared to Chewy's 8.3% in its third quarter of fiscal 2025 [8] - Walmart's global advertising sales increased by 53% year-over-year in Q3 FY26, providing potential for profit growth despite low sales growth [7] Competitive Position - Chewy offers pure exposure to the pet industry, but Walmart's broader customer base and competitive advantages position it for higher long-term gains [12]
Final Trades: Meta, S&P Global and Idexx Lab
Youtube· 2025-11-03 18:29
Group 1 - The market is experiencing a K-shaped recovery, indicating a divergence in performance between large-cap and small-cap stocks, as well as between rate-sensitive and less rate-sensitive sectors [1] - Meta is identified as a buy opportunity, currently down nearly 20% from its high, approaching bear market territory [1] - S&P Global reported a strong quarter with increased issuance, suggesting a favorable environment for the company [2] Group 2 - Idex Lab has shown significant performance, breaking above its 2021 high with double-digit revenue growth, currently up approximately 15% [2]